Eigen Bio
FRONTIER BIOLOGICAL AI

Making Human Biology
Readable

Eigen Bio reveals the biological programs that shape disease progression, treatment response, and resistance.

PLATFORM

Explore the ORIGIN platform

Eigen Bio's products are built on a single engine: a regulatory foundation model and mechanistic knowledge graph. ORIGIN helps biopharma teams translate proprietary data into actionable insight for drug development. PALADIN applies the same engine to individual patients, surfacing peer-reviewed biological evidence to support clinical decision-making. Partners retain full control of their data throughout.

Explore the Platform
EigenBio ORIGIN platform interface

RESEARCH

Published research & preprints

Our research is grounded in a simple conviction: understanding biology means understanding its response to intervention. Eigen Bio combines a foundation model trained on perturbation data with a large-scale regulatory knowledge graph to uncover mechanistic biology that is interpretable, testable, and frequently absent from existing scientific databases.

View Publications
EigenBio Research diagram

ABOUT

Meet the team behind Eigen Bio

Eigen Bio is building the intelligence substrate that medicine has always needed: a human-centered way to decode biological response. Our mission is to make human biology readable, translating complex molecular signals into insights that can advance research, drug development, and patient care. Built across San Francisco, Seoul, and New York, the company sits at the intersection of AI, molecular biology, and translational science.

About Eigen Bio
EigenBio development team